Skip to Content

Advanz Pharma Corp Ltd CXRXF

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Advanz Pharma Corp Ltd is an international specialty pharmaceutical company, owning or licensing, through its subsidiaries, a diversified portfolio of branded and generic prescription products. The company has two reportable segments, which consist of ADVANZ PHARMA International and ADVANZ PHARMA North America. In ADVANZ PHARMA North America segment revenue is derived from two customer groups, which include wholesalers and authorized generic partners. In ADVANZ PHARMA International segment revenue is recognized at the time of sale to the wholesalers, hospitals, and pharmacies.

85 King William Street, Capital House
London, EC4N 7BL, Jersey
T +44 2085889164
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Dec 31, 2019
Fiscal Year End Dec 31, 2020
Stock Type
Employees 429